1. Prediction of drug degradation pathways leading to structural alerts for potential genotoxic impurities;Raillard;Org Process Res Dev,2010
2. Strategies for the identification, control and determination of genotoxic impurities in drug substances: A pharmaceutical industry perspective;Raman;J Pharm Biomed Anal,2011
3. Guidance for industry Q3A impurities in new drug substances;International Conference on Harmonization (ICH),2008
4. Impurities in new products Q3B (R2);International Conference on Harmonization (ICH),2006
5. Fundamental structural alerts to potential carcinogenicity or noncarcinogenicity;Ashby;Environ Mutagen,1985